| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.3B | $13.7B | $10.8B | $13.6B | $12.8B | $1.8B | $1.1B | $0.6B |
| Cost of Revenue | $16.1B | $10.8B | $9.0B | $12.4B | $10.9B | $4.8B | $3.4B | — |
| Gross Profit | $4.2B | $2.9B | $1.7B | $1.2B | $1.9B | $0.2B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.3B | $1.9B | $1.8B | $2.7B | $2.0B | $1.1B | $0.8B | $0.4B |
| Operating Income | $1.9B | $1.0B | — | — | — | — | — | — |
| Net Income | $1.4B | $0.2B | $0.5B | $-1.6B | $-0.1B | $-0.1B | $-0.0B | $-0.0B |
| EPS (Basic) | $10.22 | $1.72 | $4.12 | — | — | — | — | — |
| EPS (Diluted) | $8.45 | $1.59 | $0.75 | $-15.74 | $-1.63 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $8.5B | $7.1B | $8.7B | $7.0B | $3.0B | $2.1B | $1.0B |
| Current Assets | $6.5B | $4.9B | $3.3B | $4.6B | $4.9B | $1.9B | $1.4B | $0.7B |
| Cash & Equivalents | $2.3B | $1.7B | $0.5B | $0.4B | $0.4B | $0.3B | $0.1B | $0.1B |
| Total Liabilities | $9.0B | $7.1B | $7.5B | $9.8B | $6.5B | $2.2B | $1.9B | $0.8B |
| Current Liabilities | $1.5B | $1.3B | $1.5B | $2.6B | $2.9B | $0.5B | $0.9B | $0.3B |
| Stockholders' Equity | $3.4B | $1.3B | $0.2B | $-0.5B | $0.3B | $0.4B | $0.1B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.9B | $0.8B | $-1.3B | $-2.6B | $-0.6B | $-0.8B | $-0.4B |
| Investing Cash Flow | $-0.2B | $-0.0B | $0.0B | $-2.6B | $-0.6B | $-0.3B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.5B | $0.6B | $0.4B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.1B | $0.3B | $-0.9B | $3.9B | $3.5B | $1.2B | $1.0B | $0.5B |